San Diego-based Tandem Diabetes Care, Inc. agreed to voluntarily recall insulin pumps used to manage blood sugar, the company said in an Aug. 12 announcement by the Food and Drug Administration.
Insulin pumps are wearable devices that deliver insulin at predetermined doses at specific times. Such devices can feature alarm functions to alert users about various situations, such as issues with insulin delivery.
